重要内容提示： 会议召开时间：2024 年 9 月 24 日 15:00-16:00 会议召开方式：文字网络互动 会议召开地点：证券日报网路演平台（http://www.zqrb.cn/huiyi/lyhd/ind ex.html） 证券代码：603297 证券简称：永新光学 公告编号：2024-036 宁波永新光学股份有限公司 关于召开2024年半年度网上业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 三、参加人员 公司联席董事长、总经理毛磊先生，独立董事陈世挺先生，公司财务负责人 毛凤莉女士，公司董事会秘书奚静鹏先生。 四、投资者参加方式 投资者可于 2024 年 9 月 23 日 17:00 前通过公告中的联系电话、电子邮 箱联系公司，提出所关注的问题，公司将在说明会上就投资者普遍关注的问题 进行回答。 一、说明会类型 宁波永新光学股份有限公司（以下简称"公司"）已于 2024 年 8 月 31 日在 上海证券交易所网站（www.sse.com.cn）披露了《2024 年半年度报告》。为方 便广大投资者 ...

证券代码：603297 证券简称：永新光学 公告编号：2024-037 宁波永新光学股份有限公司 关于公司联席董事长、总经理增持公司股份的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 宁波永新光学股份有限公司（以下简称"公司"）联席董事长、总经理 毛磊先生，于 2024 年 9 月 12 日通过上海证券交易所交易系统以集中竞价方式合 计增持公司股票 20,000 股，占公司总股本的 0.018%。 2024 年 9 月 12 日，公司收到公司联席董事长、总经理毛磊先生出具的《关 于增持公司股份的告知函》。其基于对公司未来发展前景、持续稳健发展的信心 及对公司价值的认可，增持公司股份，现将具体情况公告如下： | 序 | 股东名称 | 持股数量 | 持股比 | 一致行动关系形成原因 | | --- | --- | --- | --- | --- | | 号 | | （股） | 例 | | | 1 | 毛磊 | 3,250,000 | 2.924% | - | | --- | --- | --- | --- ...

Investment Rating - The investment rating for the company is "Outperform the Market" [3][14]. Core Views - The company reported a revenue growth of 9.6% year-on-year for the first half of 2024, with total revenue reaching 428 million yuan. However, net profit faced pressure, declining by 14.07% year-on-year to 100 million yuan, primarily due to a significant decrease in foreign exchange gains and increased R&D expenditures [1]. - The barcode scanning business is recovering rapidly, while the optical microscope segment has seen a decline in revenue. The optical components business, however, has shown a strong recovery, with a 30.95% increase in sales to 254 million yuan [1]. - The company is optimizing high-end microscopes and has begun small-batch shipments of complex components and modules for barcode scanning. The sales revenue from the automotive and LiDAR optical components reached nearly 70 million yuan, marking a 120% increase year-on-year [1]. - The company maintains strong partnerships with well-known domestic and international firms in the LiDAR sector, which is expected to enhance market share [1]. Financial Summary - For the first half of 2024, the company achieved a gross margin of 38.93%, with a slight decrease of 1.36 percentage points year-on-year. The gross margin for the second quarter of 2024 was 40.17%, reflecting a year-on-year decline of 1.61 percentage points but a quarter-on-quarter increase of 2.46 percentage points [1]. - The company has adjusted its revenue forecasts for 2024-2026, now expecting revenues of 1.049 billion yuan, 1.382 billion yuan, and 1.827 billion yuan respectively, down from previous estimates. Net profit forecasts have also been revised to 265 million yuan, 371 million yuan, and 482 million yuan for the same period [1][2]. - The current price-to-earnings (P/E) ratios are projected to be 23.3, 16.6, and 12.8 for 2024, 2025, and 2026 respectively [2].

Investment Rating - The report maintains a "Recommended" rating for the company [1]. Core Views - The company reported a revenue of 428 million yuan for H1 2024, representing a year-on-year growth of 9.62%. However, the net profit attributable to shareholders decreased by 14.07% to 100 million yuan [1]. - The optical microscope business saw a slight decline in revenue, achieving 163 million yuan, down 12.78% year-on-year. The company is responding to the demand for domestic high-end instruments, which is expected to accelerate recovery [1]. - The optical component business experienced a significant growth of 30.95%, driven by the recovery in barcode scanning and the mass production of LiDAR products [1]. - The company is projected to achieve revenues of 1.11 billion, 1.46 billion, and 1.86 billion yuan for 2024, 2025, and 2026 respectively, with corresponding net profits of 271 million, 353 million, and 451 million yuan [1]. Financial Summary - For H1 2024, the company achieved a gross margin of 38.93%, a decrease of 1.36 percentage points year-on-year, and a net profit margin of 23.15%, down 6.5 percentage points year-on-year [1]. - The company forecasts revenue growth rates of 30%, 31%, and 28% for the years 2024, 2025, and 2026 respectively, with net profit growth rates of 15%, 30%, and 28% [1]. - The projected earnings per share (EPS) for 2024, 2025, and 2026 are 2.44 yuan, 3.18 yuan, and 4.06 yuan respectively, with corresponding price-to-earnings (PE) ratios of 22, 17, and 13 [1][5].

Investment Rating - The report maintains a "Buy" rating for the company with a market price of 54.87 CNY and a market capitalization of 6,099 million CNY [1]. Core Insights - The company's revenue growth is driven by recovering demand, with expectations for continued upward momentum in H2 2024. The optical microscope and optical component segments achieved revenues of 163 million CNY and 254 million CNY respectively in H1 2024, with year-on-year changes of -12.8% and +31.0% [3]. - The optical components business benefits from the rapid recovery of barcode scanning and the large-scale production of LiDAR products, maintaining a gross margin of approximately 40% [3]. - The company is one of the few domestic firms capable of high-end microscope R&D and manufacturing, achieving over 4% localization in high-end microscope products priced under 3 million CNY [3]. - The automotive business has seen rapid growth, with revenues of approximately 70 million CNY in H1 2024, a year-on-year increase of 120% [3]. - The medical optics segment has grown over 50% in the past two years, with the company developing high-precision medical components and high-end medical devices for various applications [3]. - The profit forecast for 2024-2026 has been adjusted, with expected net profits of 250 million CNY, 310 million CNY, and 390 million CNY respectively, corresponding to P/E ratios of 22, 18, and 14 [3]. Financial Summary - The company's revenue for 2022 was 829 million CNY, with a projected increase to 1,072 million CNY in 2024, reflecting a year-on-year growth rate of 25.6% [3]. - Net profit for 2022 was 279 million CNY, with a forecasted net profit of 251 million CNY for 2024, indicating a growth rate of 6.6% [3]. - The gross margin is expected to improve to 40.2% by 2026, with net profit margins stabilizing around 23.9% [3].

Investment Rating - The report maintains a "Buy" rating for Yongxin Optical (603297.SH) [2] Core Views - The company achieved a revenue of 428 million yuan in H1 2024, representing a year-on-year growth of 9.62%, while the net profit attributable to shareholders was 100 million yuan, a decrease of 14.07% compared to the same period last year [3][4] - The optical component business showed significant growth, compensating for the decline in the optical microscope segment, leading to an overall revenue increase [3] - The company is implementing a "dual-engine" strategy focusing on high-end microscopes and optical components, with new high-end microscope products being developed and launched [4] - The barcode scanning and LiDAR businesses are expanding, with the barcode scanning module business expected to begin mass shipments in the second half of 2024 [4] Financial Summary - In H1 2024, the optical microscope business generated revenue of 163 million yuan, down 12.78% year-on-year, while the optical component business achieved revenue of 254 million yuan, up 30.95% year-on-year [3] - The gross profit margin for H1 2024 was 38.93%, a decrease of 1.36 percentage points year-on-year, while the net profit margin was 23.25%, down 6.41 percentage points year-on-year [3] - The company expects revenues of 1.026 billion yuan, 1.350 billion yuan, and 1.799 billion yuan for 2024, 2025, and 2026 respectively, with net profits projected at 260 million yuan, 344 million yuan, and 479 million yuan for the same years [5][9]

Investment Rating - The report maintains a "Recommend" rating for Yongxin Optics (603297 SH) [2][3] Core Views - Yongxin Optics' H1 2024 performance met expectations with revenue of 428 million yuan, up 9 5% YoY, and net profit attributable to the parent company of 100 million yuan, down 13 8% YoY [1] - The company's Q2 2024 revenue was 212 million yuan, up 4 4% YoY, with a net profit attributable to the parent company of 54 million yuan, down 21 7% YoY [1] - The optical microscope business is expected to recover rapidly in H2 2024, driven by policy acceleration and historical data analysis [1] - The optical components business achieved revenue of 254 million yuan in H1 2024, up 30 95% YoY, driven by the recovery of barcode scanning business and the mass production of lidar products [1] Business Performance Optical Microscope Business - Revenue from the optical microscope business in H1 2024 was 163 million yuan, down 12 78% YoY [1] - The company has achieved over 4% localization in high-end microscopes, with expectations of accelerated recovery due to national policy support [2] Optical Components Business - The barcode scanning business rebounded strongly due to inventory digestion and overseas demand recovery [2] - The company secured several AR-HUD project contracts, with terminal products to be used by leading foreign automakers [2] - Revenue from the automotive business in H1 2024 was nearly 70 million yuan, up 120% YoY [2] - The medical imaging business maintained steady growth, supplying optical components to global leading medical device companies [2] Financial Forecasts - Revenue for 2024E is projected at 1,108 million yuan, with a growth rate of 29 7% [2] - Net profit attributable to the parent company for 2024E is forecasted at 267 million yuan, with a growth rate of 13 4% [2] - EPS for 2024E is expected to be 2 40 yuan, with a PE ratio of 21x [2] - Revenue for 2026E is projected at 2,040 million yuan, with a growth rate of 35 6% [2] - Net profit attributable to the parent company for 2026E is forecasted at 497 million yuan, with a growth rate of 29 3% [2] Valuation and Key Metrics - The company's PE ratio for 2024E is 21x, decreasing to 11x by 2026E [2] - The PB ratio for 2024E is 2 8x, decreasing to 2 1x by 2026E [2] - The EV/EBITDA ratio for 2024E is 18 53x, decreasing to 10 26x by 2026E [4] - The dividend yield is expected to remain stable at 1 92% from 2024E to 2026E [4]

Investment Rating - The investment rating for the company is maintained at "Buy-A" with a 6-month target price of 60.00 CNY, which corresponds to a dynamic price-to-earnings ratio of 25.00x for 2024 [6][8]. Core Views - The company reported a revenue of 428 million CNY for H1 2024, representing a year-on-year growth of 9.62%. However, the net profit attributable to shareholders decreased by 14.07% to 99.59 million CNY [2]. - The optical microscope business faced temporary pressure in H1 2024, with revenues declining by 12.78% to 163 million CNY. However, government policies aimed at supporting equipment upgrades are expected to drive recovery in the second half of the year [3]. - The optical components business saw significant growth, with sales increasing by 30.95% to 254 million CNY in H1 2024, driven by the recovery of barcode scanning and the mass production of LiDAR products [4]. - The company is actively expanding its medical optics business, which has achieved over 50% growth in the past two years, focusing on high-precision medical components [5][7]. Financial Performance Summary - For H1 2024, the company achieved a gross profit margin of 40.17%, an increase of 2.46 percentage points from the previous quarter [2]. - The projected revenue growth rates for 2024 to 2026 are 20.32%, 36.66%, and 28.56%, respectively, while net profit growth rates are expected to be 13.30%, 34.92%, and 28.93% [8]. - The company’s total market capitalization is approximately 5.94 billion CNY, with a circulating market capitalization of about 5.90 billion CNY [6].

证券代码：603297 证券简称：永新光学 公告编号：2024-034 宁波永新光学股份有限公司 关于回购注销部分限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 宁波永新光学股份有限公司（以下简称"公司"）于 2024 年 8 月 29 日召 开第八届董事会第九次会议和第八届监事会第八次会议，分别审议通过了《关于 回购注销部分限制性股票的议案》，同意对公司 2023 年限制性股票激励计划（以 下简称"本次激励计划"或"《激励计划》"）预留部分授予的激励对象已获授 但不具备解锁条件的限制性股票进行回购注销。现将有关事项说明如下： 一、本次回购注销部分限制性股票事项的授权及批准情况 1、2023 年 7 月 4 日及 2023 年 7 月 21 日，公司分别召开第七届董事会第二 十二次会议、第七届监事会第二十次会议及 2023 年第一次临时股东大会，审议 通过了《关于<公司 2023 年限制性股票激励计划（草案）>及其摘要的议案》《关 于<公司 2023 年限制性股票激励计划实施考核管理办法>的议案》以及《关于提 ...

证券代码：603297 证券简称：永新光学 公告编号：2024-033 宁波永新光学股份有限公司 第八届监事会第八次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 宁波永新光学股份有限公司（以下简称"公司"）于 2024 年 8 月 19 日以电 子邮件及专人送达方式发出了关于召开公司第八届监事会第八次会议的通知，本 次会议于 2024 年 8 月 29 日在公司会议室召开。会议应出席监事 3 名，实际出席 监事 3 名。本次会议由监事会主席周辉先生主持。本次会议的召开符合《中华人 民共和国公司法》和《公司章程》的有关规定，所作决议合法有效。 二、监事会会议审议情况 经过充分讨论，会议审议并通过了如下决议： 1、审议并通过《2024 年半年度报告全文及摘要》 具体内容详见公司刊载于上海证券交易所网站（www.sse.com.cn）和公司指 定信息披露媒体的《2024 年半年度报告》全文及《2024 年半年度报告摘要》。 表决结果：同意 3 票；反对 0 票；弃权 0 票。 监事会认为：鉴于 ...